BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35964181)

  • 1. The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy.
    Piccarducci R; Caselli MC; Zappelli E; Ulivi L; Daniele S; Siciliano G; Ceravolo R; Mancuso M; Baldacci F; Martini C
    J Alzheimers Dis; 2022; 89(3):1039-1049. PubMed ID: 35964181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients.
    Daniele S; Baldacci F; Piccarducci R; Palermo G; Giampietri L; Manca ML; Pietrobono D; Frosini D; Nicoletti V; Tognoni G; Giorgi FS; Lo Gerfo A; Petrozzi L; Cavallini C; Franzoni F; Ceravolo R; Siciliano G; Trincavelli ML; Martini C; Bonuccelli U
    J Alzheimers Dis; 2021; 80(2):885-893. PubMed ID: 33579836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (Aβ) and colocalizes with deposited Aβ in cerebral amyloid angiopathy.
    de Jager M; Boot MV; Bol JG; Brevé JJ; Jongenelen CA; Drukarch B; Wilhelmus MM
    Neuropathol Appl Neurobiol; 2016 Apr; 42(3):255-72. PubMed ID: 25871449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal Fluid Biomarkers in Cerebral Amyloid Angiopathy.
    Banerjee G; Ambler G; Keshavan A; Paterson RW; Foiani MS; Toombs J; Heslegrave A; Dickson JC; Fraioli F; Groves AM; Lunn MP; Fox NC; Zetterberg H; Schott JM; Werring DJ
    J Alzheimers Dis; 2020; 74(4):1189-1201. PubMed ID: 32176643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
    Gkanatsiou E; Portelius E; Toomey CE; Blennow K; Zetterberg H; Lashley T; Brinkmalm G
    Neurosci Lett; 2019 May; 701():125-131. PubMed ID: 30807796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.
    Renard D; Wacongne A; Ayrignac X; Charif M; Fourcade G; Azakri S; Le Floch A; Bouly S; Marelli C; Arquizan C; Hirtz C; Gabelle A; Thouvenot E; Lehmann S
    J Alzheimers Dis; 2016; 50(3):759-764. PubMed ID: 26757185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics.
    Muir RT; Ismail Z; Black SE; Smith EE
    Alzheimers Dement; 2024 Feb; 20(2):1436-1458. PubMed ID: 37908054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
    Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
    Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation.
    Renard D; Collombier L; Demattei C; Wacongne A; Charif M; Ayrignac X; Azakri S; Gaillard N; Boudousq V; Lehmann S; Menjot de Champfleur N; Thouvenot E
    J Alzheimers Dis; 2018; 61(3):1107-1117. PubMed ID: 29254099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria.
    Renard D; Castelnovo G; Wacongne A; Le Floch A; Thouvenot E; Mas J; Gabelle A; Labauge P; Lehmann S
    J Neurol; 2012 Nov; 259(11):2429-33. PubMed ID: 22576334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-talk between Aβ and endothelial SSAO/VAP-1 accelerates vascular damage and Aβ aggregation related to CAA-AD.
    Solé M; Miñano-Molina AJ; Unzeta M
    Neurobiol Aging; 2015 Feb; 36(2):762-75. PubMed ID: 25457560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer's Disease.
    Wheeler KV; Irimia A; Braskie MN
    J Alzheimers Dis; 2024; 97(4):1479-1502. PubMed ID: 38306032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of proteins related neurodegeneration in autopsy brains of the aged].
    Zhu M; Meng X; Wang L; Hu Y; Zhang H; Han Z
    Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):651-6. PubMed ID: 25567589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Diagnostic Value of Red Blood Cells α-Synuclein Heteroaggregates in Alzheimer's Disease.
    Baldacci F; Daniele S; Piccarducci R; Giampietri L; Pietrobono D; Giorgi FS; Nicoletti V; Frosini D; Libertini P; Lo Gerfo A; Petrozzi L; Donadio E; Betti L; Trincavelli ML; Siciliano G; Ceravolo R; Tognoni G; Bonuccelli U; Martini C
    Mol Neurobiol; 2019 Sep; 56(9):6451-6459. PubMed ID: 30826968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling amyloid-β peptides as biomarkers for cerebral amyloid angiopathy.
    van den Berg E; Kersten I; Brinkmalm G; Johansson K; de Kort AM; Klijn CJM; Schreuder FHBM; Gobom J; Stoops E; Portelius E; Gkanatsiou E; Zetterberg H; Blennow K; Kuiperij HB; Verbeek MM
    J Neurochem; 2024 Feb; ():. PubMed ID: 38362804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between cerebral amyloid angiopathy and cortical microinfarcts in brain ageing and Alzheimer's disease.
    Kövari E; Herrmann FR; Hof PR; Bouras C
    Neuropathol Appl Neurobiol; 2013 Aug; 39(5):498-509. PubMed ID: 23163235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for cerebral amyloid angiopathy based on serological biomarkers analysis using a dielectrophoretic force-driven biosensor platform.
    Kim HJ; Park D; Yun G; Kim H; Kim HG; Lee KM; Hong IK; Park KC; Lee JS; Hwang KS
    Lab Chip; 2021 Nov; 21(23):4557-4565. PubMed ID: 34724019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta-analysis.
    Charidimou A; Friedrich JO; Greenberg SM; Viswanathan A
    Neurology; 2018 Feb; 90(9):e754-e762. PubMed ID: 29386280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity.
    Daniele S; Frosini D; Pietrobono D; Petrozzi L; Lo Gerfo A; Baldacci F; Fusi J; Giacomelli C; Siciliano G; Trincavelli ML; Franzoni F; Ceravolo R; Martini C; Bonuccelli U
    Front Mol Neurosci; 2018; 11():53. PubMed ID: 29520218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF and plasma biomarkers in cerebral amyloid angiopathy: A single-center study and a systematic review/meta-analysis.
    Theodorou A; Tsantzali I; Stefanou MI; Sacco S; Katsanos AH; Shoamanesh A; Karapanayiotides T; Koutroulou I; Stamati P; Werring DJ; Cordonnier C; Palaiodimou L; Zompola C; Boviatsis E; Stavrinou L; Frantzeskaki F; Steiner T; Alexandrov AV; Paraskevas GP; Tsivgoulis G
    Eur Stroke J; 2024 Jun; ():23969873241260538. PubMed ID: 38869035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.